Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Other Non-Current Liabilities: 2019

  • Avidity Biosciences' Other Non-Current Liabilities was N/A to $45,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $45,000, marking a year-over-year change of. This contributed to the annual value of $45,000 for FY2019, which is N/A change from last year.
  • According to the latest figures from Q4 2019, Avidity Biosciences' Other Non-Current Liabilities is $45,000.
  • In the past 5 years, Avidity Biosciences' Other Non-Current Liabilities registered a high of $45,000 during Q4 2019, and its lowest value of $45,000 during Q4 2019.
  • Moreover, its 1-year median value for Other Non-Current Liabilities was $45,000 (2019), whereas its average is $45,000.